BRAzil magnesium (BRAMAG) trial: a double-masked randomized clinical trial of oral magnesium supplementation in pregnancy

Carla Adriane Leal de Araújo, Joel Geoffrey Ray, José Natal Figueiroa, João Guilherme Alves, Carla Adriane Leal de Araújo, Joel Geoffrey Ray, José Natal Figueiroa, João Guilherme Alves

Abstract

Background: There is conflicting evidence about the role of oral magnesium supplementation in the prevention of preterm birth and related adverse outcomes. The objective of this study was to compare magnesium citrate with placebo in the prevention of adverse perinatal and maternal outcomes among women at higher risk.

Methods: This multicenter, double-masked, placebo-controlled randomized superiority clinical trial compared oral magnesium citrate 300 mg to matched placebo, from 12 to 20 weeks' gestation until delivery. This trial was completed in three centers in northeastern Brazil. Eligible women were those with a singleton pregnancy and ≥ 1 risk factor, such as prior preterm birth or preeclampsia, or current chronic hypertension or pre-pregnancy diabetes mellitus, age > 35 years or elevated body mass index. The primary perinatal composite outcome comprised preterm birth < 37 weeks' gestation, stillbirth > 20 weeks, neonatal death or NICU admission < 28 days after birth, or small for gestational age birthweight < 3rd percentile. The co-primary maternal composite outcome comprised preeclampsia or eclampsia < 37 weeks, severe gestational hypertension < 37 weeks, placental abruption, or maternal stroke or death during pregnancy or ≤ 7 days after delivery.

Results: Analyses comprised 407 women who received magnesium citrate and 422 who received placebo. The perinatal composite outcome occurred among 75 (18.4%) in the magnesium arm and 76 (18.0%) in the placebo group - an adjusted odds ratio (aOR) of 1.10 (95% CI 0.72-1.68). The maternal composite outcome occurred among 49 (12.0%) women in the magnesium arm and 41 women (9.7%) in the placebo group - an aOR of 1.29 (95% CI 0.83-2.00).

Conclusions: Oral magnesium citrate supplementation did not appear to reduce adverse perinatal or maternal outcomes in high-risk singleton pregnancies.

Trial registration: ClinicalTrials.gov NCT02032186, registered January 9, 2014.

Keywords: Magnesium; Newborn; Preeclampsia; Pregnancy; Preterm birth; Randomized clinical trial.

Conflict of interest statement

None.

Figures

Fig. 1
Fig. 1
Flow diagram of participant recruitment, randomization and follow-up

References

    1. WHO. Preterm birth. Available at: [accessed December 4, 2019]..
    1. Newnham JP, Kemp MW, White SW, Arrese CA, Hart RJ, Keelan JA. Applying precision public health to prevent preterm birth. Public Health. 2017;5:66.
    1. McCabe ER, Carrino GE, Russel RB, Howse JL. Fighting for the next generation: US prematurity in 2030. Pediatrics. 2014;134(6):1193–1199.
    1. Blencowe H, Cousens S, Chou D, Oestergaard MZ, Say L, Moller AB, et al. Born too soon: the global epidemiology of 15 million preterm births. Reprod Health. 2013;10(Suppl1):S2–14.
    1. Araya BM, Díaz M, Paredes D, Ortiz J. Association between preterm birth and its subtypes and maternal sociodemographic characteristics during the post-transitional phase in a developing country with a very high human development index. Public Health. 2017;147:39–46.
    1. Strizke A, Thomas, Amin H, Fusch C, Lodha A. Renal consequences of preterm birth. Mol Cell Pediatr. 2017;4(1):2–9.
    1. Hovi P, Vohr B, Ment LR, Doyke LW, McGarvey L, Morrison KM, et al. Blood pressure in young adults born at very low birth weight: adults born preterm international collaboration. Hypertension. 2016;68(4):880–887.
    1. Bolton CE, Bush A, Hurst JR, Kotecha S, McGarvey L. Lung consequences in adults born prematurely. Thorax. 2015;70:574–580.
    1. Raju TNK, Buist AS, Blaisdell CJ, Moxey-Mims M, Saigal S. Adults born preterm: a review of general health and system-specific outcomes. Acta Paediatr. 2017;106(9):1409–1437.
    1. Soilly AL, Lejeune C, Quantin C, Bejean S, Gouyon JB. Economic analysis of the costs associated with prematurity from a literature review. Public Health. 2014;128(1):43–62.
    1. Blac L, Hulsey T, Lee K, Parks DC, Ebeling MD. Incremental hospital costs associated with comorbidities of prematurity. Manag Care. 2015;24(12):54–60.
    1. DATASUS Estatísticas vitais. Available at: . [accessed May 14, 2019].
    1. França EB, Lansky S, MAS R, Malta DC, França JS, Teixeira R, et al. Principais causas de mortalidade na infância no Brasil, em 1990 e 2015: estimativas do estudo de Carga Global de Doença. Rev Bras epidemiol. 2017;20(1):46–60.
    1. do Carmo Leal M, Esteves-Pereira AP, Nakamura-Pereira M, Torres JA, Theme-Filha M, Domingues RMSM, et al. Prevalence and risk factors related to preterm birth in Brazil. Reprod Health. 2016;13(Suppl 3):164–175.
    1. Leal MC, Esteves-Pereira AO, Nakamura-Pereira N, Torres JA, Theme-Filha M, Domingues RM, et al. Prevalence and risk factors related to preterm birth in Brazil. Reprod Health. 2016;13(Suppl 3):127.
    1. Veronese N, Demurtas J, Pesolillo G, Celotto S, Barnini T, Calusi G, et al. Magnesium and health outcomes: an umbrella review of systematic reviews and meta-analyses of observational and intervention studies. Eur J Nutr. 2019 Jan 25. 10.1007/s00394-019-01905-w.
    1. Jain S, Sharma P, Kulshreshtha S, Mohan G, Singh S. The role of calcium, magnesium, and zinc in pre-eclampsia. Biol Trace Elem Res. 2010;133:162–170.
    1. Idogun ES, Imarengiaye CO, Momoh SM. Extracellular calcium and magnesium in preeclampsia and eclampsia. Afr J Reprod Health. 2007;11:89–94.
    1. Indumati V, Kodliwadmath MV, Sheela MK. The role of serum electrolytes in pregnancy induced hypertension. J Clin Diagnostic Res. 2011;5:65–69.
    1. Enaruna NO, Ande A, Okpere EE. Clinical significance of low serum magnesium in pregnant women attending the University of Benin Teaching Hospital. Niger J Clin Pract. 2013;16(4):448–453.
    1. Alves JG, de Araújo CA, Pontes IE, Guimarães AC, Ray JG. The BRAzil MAGnesium (BRAMAG) trial: a randomized clinical trial of oral magnesium supplementation in pregnancy for the prevention of preterm birth and perinatal and maternal morbidity. BMC Pregnancy Childbirth. 2014;14:222.
    1. de Baaij JH, Hoenderop JG, Bindels RJ. Magnesium in man: implications for health and disease. Physiol Rev. 2015;95(1):1–46.
    1. Makrides M, Crosby DD, Bain E, Crowther CA. Magnesium supplementation in pregnancy. Cochrane Database Syst Rev. 2014;4:Cd000937.
    1. Spätling L, Spätling G. Magnesium supplementation in pregnancy. A double-blind study. Br J Obstet Gynaecol. 1988;95(2):120–125.
    1. Sibai BM, Villar MA, Brazy E. Magnesium supplementation during pregnancy: a double-blind randomized controlled clinical trial. Am J Obstet Gynecol. 1989;161:115–119.
    1. DÀlmeida A, Carter JP, Anatol A, Prost C. Effects of a combination of evening primrose oil (gamma linolenic acid) and fish oil (eicosapentaenoic + docahexaenoic acid) versus magnesium, versus placebo in preventing pre-eclampsia. Women Health. 1992;19(2–3):117–131.
    1. Martin RW, Perry KG, Jr, Hess LW, Martin JN, Jr, Morrison JC. Oral magnesium and the prevention of preterm labor in a high-risk group of patients. Am J Obstet Gynecol. 1992;166:144–147.
    1. Dahle LO, Berg G, Hammar M, Hurtig M, Larsson L. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol. 1995;173(1):175–180.
    1. Meier B, Huch R, Zimmermann R, von Mandach U. Does continuing oral magnesium supplementation until delivery affect labor and puerperium outcome? Eur J Obstet Gynecol Reprod Biol. 2005;123:157–161.
    1. Harrison V, Fawcus S, Jordaan E. Magnesium supplementation and perinatal hypoxia: outcome of a parallel group randomised trial in pregnancy. BJOG. 2007;114:994–1002.
    1. Nygaard IH, Valbø A, Pethick SV, Bøhmer T. Does oral magnesium substitution relieve pregnancy-induced leg cramps? Eur J Obstet Gynecol Reprod Biol. 2008;141:23–26.
    1. Bullarbo M, Ödman N, Nestler A, et al. Magnesium supplementation to prevent high blood pressure in pregnancy: a randomised placebo control trial. Arch Gynecol Obstet. 2013;288:1269–1274.
    1. Walker AF, Marakis G, Christie S, Byng M. Mg citrate found more bioavailable than other mg preparations in a randomised, double-blind study. Magnes Res. 2003;16:183–191.
    1. Gröber U, Schmidt J, Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7(9):8199–8226.
    1. Pathak P, Kapil U, Kapoor SK, Saxena R, Kumar A, Gupta N, Dwivedi SN, Singh R, Singh P. Prevalence of multiple micronutrient deficiencies amongst pregnant women in a rural area of Haryana. Indian J Pediatr. 2004;71(11):1007–1014.
    1. Tabrizi FM, Pakdel FG. Serum Level of Some Minerals during Three Trimesters of Pregnancy in Iranian Women and Their Newborns: A Longitudinal Study. Indian J Clin Biochem. 2014;29(2):174–180.
    1. Rocha VS, Lavanda I, Nakano EY, Ruano R, Zugaib M, Colli C. Calcium and magnesium status is not impaired in pregnant women. Nutr Res. 2012;32(7):542–546.
    1. Okunade KS, Oluwole AA, Adegbesan-Omilabu MA. A Study on the Association between Low Maternal Serum Magnesium Level and Preterm Labour. Adv Med. 2014;2014:704875.
    1. Arikan GM, Panzitt T, Gücer F, et al. Course of maternal serum magnesium levels in low-risk gestations and in preterm labor and delivery. Fetal Diagn Ther. 1999;14:332–336.
    1. Zarean E, Tarjan A. Effect of magnesium supplement on pregnancy outcomes: a randomized control trial. Adv Biomed Res. 2017;6:109–114.
    1. DATASUS. Estatísticas vitais. Available at: http//. [Accessed in May 14, 2019]..
    1. Souza AI, de Siqueira MT, Ferreira ALCG, de Freitas CU, Bezerra ACV, Ribeiro AG, Nardocci AC. Geography of Microcephaly in the Zika Era: A Study of Newborn Distribution and Socio-environmental Indicators in Recife, Brazil, 2015-2016. Public Health Rep. 2018;133(4):461–471.

Source: PubMed

Sponsorer og samarbeidspartnere

Medisinsk tilstand

Legemiddelintervensjoner

3
Abonnere